首页 > 最新文献

Diabetology International最新文献

英文 中文
In vivo relationship between bound and free insulin in patients with diabetes having anti-insulin antibodies. 具有抗胰岛素抗体的糖尿病患者体内结合胰岛素和游离胰岛素之间的关系。
IF 1.3 Q3 Medicine Pub Date : 2023-06-20 eCollection Date: 2023-10-01 DOI: 10.1007/s13340-023-00641-1
Hiroyuki Asaka, Shigehiro Karashima, Daisuke Chujo, Mitsuhiro Kometani, Mikiya Usukura, Kunimasa Yagi, Ko Aiga, Takashi Yoneda

Objective: The Scatchard plot of anti-insulin antibodies is curvilinear, indicating heterogeneity in binding sites. However, the relationship between bound insulin (B) and free insulin (F) in patients with anti-insulin antibodies has not yet been elucidated. This study aimed to determine this relationship.

Methods: We studied two insulin-treated patients with diabetes who had high titers of anti-insulin antibodies. The B and F levels were measured using daily blood samples. Assuming that the law of mass action is applicable to the reactions between insulin and anti-insulin antibody forms, we plotted the bound-to-free ratio (B/F) vs. B using patient data. We also performed an equilibrium binding assay in vitro.

Results: Some of the B/F vs. B plots of the daily variation showed an approximately linear relationship, while the Scatchard plots of in vitro data became curvilinear.

Conclusion: Our study suggests that the one-site (high-affinity site) of anti-insulin antibodies accounts, for the most part, for insulin pharmacokinetics within physiological insulin concentrations.

Supplementary information: The online version contains supplementary material available at 10.1007/s13340-023-00641-1.

目的:抗胰岛素抗体的Scatchard图是曲线图,表明结合位点的异质性。然而,抗胰岛素抗体患者的结合胰岛素(B)和游离胰岛素(F)之间的关系尚未阐明。本研究旨在确定这种关系。方法:我们研究了两名胰岛素治疗的糖尿病患者,他们具有高滴度的抗胰岛素抗体。使用每日血液样本测量B和F水平。假设质量作用定律适用于胰岛素和抗胰岛素抗体形式之间的反应,我们使用患者数据绘制了结合自由比(B/F)与B的关系图。我们还在体外进行了平衡结合测定。结果:一些每日变化的B/F与B图显示出近似线性关系,而体外数据的Scatchard图则变为曲线。结论:我们的研究表明,抗胰岛素抗体的一个位点(高亲和力位点)在很大程度上解释了生理胰岛素浓度下的胰岛素药代动力学。补充信息:在线版本包含补充材料,可访问10.1007/s13340-023-00641-1。
{"title":"In vivo relationship between bound and free insulin in patients with diabetes having anti-insulin antibodies.","authors":"Hiroyuki Asaka, Shigehiro Karashima, Daisuke Chujo, Mitsuhiro Kometani, Mikiya Usukura, Kunimasa Yagi, Ko Aiga, Takashi Yoneda","doi":"10.1007/s13340-023-00641-1","DOIUrl":"10.1007/s13340-023-00641-1","url":null,"abstract":"<p><strong>Objective: </strong>The Scatchard plot of anti-insulin antibodies is curvilinear, indicating heterogeneity in binding sites. However, the relationship between bound insulin (B) and free insulin (F) in patients with anti-insulin antibodies has not yet been elucidated. This study aimed to determine this relationship.</p><p><strong>Methods: </strong>We studied two insulin-treated patients with diabetes who had high titers of anti-insulin antibodies. The B and F levels were measured using daily blood samples. Assuming that the law of mass action is applicable to the reactions between insulin and anti-insulin antibody forms, we plotted the bound-to-free ratio (B/F) vs. B using patient data. We also performed an equilibrium binding assay in vitro.</p><p><strong>Results: </strong>Some of the B/F vs. B plots of the daily variation showed an approximately linear relationship, while the Scatchard plots of in vitro data became curvilinear.</p><p><strong>Conclusion: </strong>Our study suggests that the one-site (high-affinity site) of anti-insulin antibodies accounts, for the most part, for insulin pharmacokinetics within physiological insulin concentrations.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13340-023-00641-1.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41119200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of diabetes medications in adults with T2D and CVD in Japan: secondary analysis of the CAPTURE study. 日本成人T2D和CVD患者糖尿病药物的使用:CAPTURE研究的二次分析。
IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-06-15 eCollection Date: 2023-10-01 DOI: 10.1007/s13340-023-00638-w
Yukiko Onishi, Shinichiro Shirabe, Kosei Eguchi, Keiji Nishijima, Toshihiro Sato, Hiroaki Seino

Introduction: The CAPTURE study estimated the global prevalence of established cardiovascular disease (CVD) and characterized the usage of glucose-lowering agents (GLAs) in adults with type 2 diabetes (T2D) across 13 countries. The purpose of this secondary analysis of data from the Japanese sites within CAPTURE (NCT03786406, NCT03811288) was to provide data about medication usage stratified by CVD status among Japanese participants with T2D.

Materials and methods: Data on GLA usage (including those with proven cardiovascular [CV] benefits) in Japanese participants with T2D managed in clinics or hospitals were collected and stratified by CVD subgroups.

Results: There were 800 Japanese participants in the CAPTURE study (n = 502 [no CVD group], n = 298 [CVD group], n = 268 [atherosclerotic CVD subgroup]). Oral antidiabetic agents and insulin were used by 88.5% and 23.4%, respectively, of participants overall. Among participants with established CVD, dipeptidyl peptidase-4 inhibitors (65.1%) were most frequently used, followed by biguanides (50.7%) and insulins (26.2%). The pattern was similar among participants with atherosclerotic CVD. A lower proportion of participants in the CVD group used glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT-2is) with proven CV benefits versus the no CVD group (GLP-1 RAs: 7.0% vs. 8.6%; SGLT-2is: 13.4% vs. 19.1%).

Conclusion: This analysis of the CAPTURE study provided a comprehensive overview of prescription patterns for the treatment of T2D in Japan. Use of GLAs with proven CV benefit was low, even in participants with established CVD, which was comparable to the findings from the global cohort.

Supplementary information: The online version contains supplementary material available at 10.1007/s13340-023-00638-w.

引言:CAPTURE研究估计了全球心血管疾病(CVD)的患病率,并描述了13个国家成人2型糖尿病(T2D)患者使用降血糖剂的情况。对CAPTURE(NCT03786406,NCT03811288)内日本站点的数据进行二次分析的目的是提供日本T2D参与者中按CVD状态分层的药物使用数据。材料和方法:收集在诊所或医院管理的日本T2D患者的GLA使用数据(包括经证实具有心血管[CV]益处的数据)并按CVD亚组进行分层。结果:共有800名日本人参与了CAPTURE研究(n = 502[无CVD组],n = 298[CVD组],n = 268[动脉粥样硬化性CVD亚组])。总体而言,88.5%和23.4%的参与者分别使用了口服抗糖尿病药物和胰岛素。在已确诊的心血管疾病参与者中,二肽基肽酶-4抑制剂(65.1%)最常使用,其次是双胍类(50.7%)和胰岛素类(26.2%)。动脉粥样硬化性心血管疾病参与者的使用模式相似。与无CVD组相比,CVD组中使用胰高血糖素样肽-1受体激动剂(GLP-1 RAs)和钠-葡萄糖协同转运蛋白-2抑制剂(SGLT-2is)的参与者比例较低(GLP-1 RAs:7.0%vs.8.6%;SGLT-2is:113.4%vs.19.1%)T2D在日本。即使在患有心血管疾病的参与者中,使用经证实具有心血管疾病益处的GLAs的情况也很低,这与全球队列的研究结果相当。补充信息:在线版本包含补充材料,网址为10.1007/s13340-023-00638-w。
{"title":"Use of diabetes medications in adults with T2D and CVD in Japan: secondary analysis of the CAPTURE study.","authors":"Yukiko Onishi, Shinichiro Shirabe, Kosei Eguchi, Keiji Nishijima, Toshihiro Sato, Hiroaki Seino","doi":"10.1007/s13340-023-00638-w","DOIUrl":"10.1007/s13340-023-00638-w","url":null,"abstract":"<p><strong>Introduction: </strong>The CAPTURE study estimated the global prevalence of established cardiovascular disease (CVD) and characterized the usage of glucose-lowering agents (GLAs) in adults with type 2 diabetes (T2D) across 13 countries. The purpose of this secondary analysis of data from the Japanese sites within CAPTURE (NCT03786406, NCT03811288) was to provide data about medication usage stratified by CVD status among Japanese participants with T2D.</p><p><strong>Materials and methods: </strong>Data on GLA usage (including those with proven cardiovascular [CV] benefits) in Japanese participants with T2D managed in clinics or hospitals were collected and stratified by CVD subgroups.</p><p><strong>Results: </strong>There were 800 Japanese participants in the CAPTURE study (<i>n</i> = 502 [no CVD group], <i>n</i> = 298 [CVD group], <i>n</i> = 268 [atherosclerotic CVD subgroup]). Oral antidiabetic agents and insulin were used by 88.5% and 23.4%, respectively, of participants overall. Among participants with established CVD, dipeptidyl peptidase-4 inhibitors (65.1%) were most frequently used, followed by biguanides (50.7%) and insulins (26.2%). The pattern was similar among participants with atherosclerotic CVD. A lower proportion of participants in the CVD group used glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT-2is) with proven CV benefits versus the no CVD group (GLP-1 RAs: 7.0% vs. 8.6%; SGLT-2is: 13.4% vs. 19.1%).</p><p><strong>Conclusion: </strong>This analysis of the CAPTURE study provided a comprehensive overview of prescription patterns for the treatment of T2D in Japan. Use of GLAs with proven CV benefit was low, even in participants with established CVD, which was comparable to the findings from the global cohort.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13340-023-00638-w.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2023-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41102192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glucose-lowering effects of semaglutide compared with dulaglutide using professional continuous glucose monitoring in outpatients with type 2 diabetes mellitus: a pilot study. 在门诊2型糖尿病患者中,使用专业连续血糖监测,与杜拉鲁肽相比,赛马鲁肽的血糖降低效果:一项初步研究。
IF 2.2 Q3 Medicine Pub Date : 2023-06-06 eCollection Date: 2023-10-01 DOI: 10.1007/s13340-023-00640-2
Akira Kurozumi, Yosuke Okada, Momo Saitoh, Yoshiya Tanaka

Objective: Currently, the most frequently prescribed once weekly glucagon-like peptide-1 receptor agonists (GLP-1RA) in Japan are dulaglutide (DG) and semaglutide (SG). However, little is known about the differences between these two compounds in clinical practice in Japan. This study compared the efficacy and safety of DG and SG using professional CGM in 12 patients attending our outpatient with poorly controlled type 2 diabetes mellitus (T2DM) while using GLP-1RA.

Methods: The study subjects were 12 T2DM patients with HbA1c ≥ 7.0% on treatment with 0.75 mg/week DG for at least 24 weeks. All patients wore the professional CGM twice, once while receiving DG and once when the SG dose was increased to 0.5 mg/week.

Results: Time in range was significantly better with SG than with DG, which was the main outcome measure. Regarding the secondary outcome measures, standard deviation of glucose, average sensor glucose, time above range, maximum sensor glucose, interquartile range, SD of glucose during the nocturnal period (0000-0559), and average nocturnal sensor glucose (0000-0559) were significantly better with SG than DG. In contrast, SG had no effect on the time below range and minimum sensor glucose compared to DG.

Conclusions: Switching from 0.75 mg DG to 0.5 mg SG in patients with T2DM improved glycemic variability, mean glycemic index, and daily variability without increasing the hypoglycemic index. The results suggest that switching to SG may be a useful option in patients experiencing inadequate glycemic control with DG.

Supplementary information: The online version contains supplementary material available at 10.1007/s13340-023-00640-2.

目的:目前,在日本,最常见的每周一次的胰高血糖素样肽-1受体激动剂(GLP-1RA)是杜拉鲁肽(DG)和塞米鲁肽(SG)。然而,在日本的临床实践中,人们对这两种化合物之间的差异知之甚少。本研究比较了DG和SG使用专业CGM治疗12例2型糖尿病(T2DM)患者的疗效和安全性 ≥ 用0.75mg/周DG治疗至少24周后为7.0%。所有患者均佩戴专业CGM两次,一次在接受DG时,一次当SG剂量增加到0.5 mg/周时。结果:SG的范围内时间明显好于DG,这是主要的结果指标。关于次要结果测量,SG的葡萄糖标准差、平均传感器葡萄糖、高于范围的时间、最大传感器葡萄糖、四分位间距、夜间血糖的SD(0000-0559)和平均夜间传感器葡萄糖(0000-059)显著优于DG。相反,与DG相比,SG对低于范围的时间和最小传感器葡萄糖没有影响。结论:T2DM患者从0.75 mg DG切换到0.5 mg SG改善了血糖变异性、平均血糖指数和每日变异性,但没有增加低血糖指数。结果表明,对于DG血糖控制不足的患者,改用SG可能是一个有用的选择。补充信息:在线版本包含补充材料,可访问10.1007/s13340-023-00640-2。
{"title":"Glucose-lowering effects of semaglutide compared with dulaglutide using professional continuous glucose monitoring in outpatients with type 2 diabetes mellitus: a pilot study.","authors":"Akira Kurozumi, Yosuke Okada, Momo Saitoh, Yoshiya Tanaka","doi":"10.1007/s13340-023-00640-2","DOIUrl":"10.1007/s13340-023-00640-2","url":null,"abstract":"<p><strong>Objective: </strong>Currently, the most frequently prescribed once weekly glucagon-like peptide-1 receptor agonists (GLP-1RA) in Japan are dulaglutide (DG) and semaglutide (SG). However, little is known about the differences between these two compounds in clinical practice in Japan. This study compared the efficacy and safety of DG and SG using professional CGM in 12 patients attending our outpatient with poorly controlled type 2 diabetes mellitus (T2DM) while using GLP-1RA.</p><p><strong>Methods: </strong>The study subjects were 12 T2DM patients with HbA1c ≥ 7.0% on treatment with 0.75 mg/week DG for at least 24 weeks. All patients wore the professional CGM twice, once while receiving DG and once when the SG dose was increased to 0.5 mg/week.</p><p><strong>Results: </strong>Time in range was significantly better with SG than with DG, which was the main outcome measure. Regarding the secondary outcome measures, standard deviation of glucose, average sensor glucose, time above range, maximum sensor glucose, interquartile range, SD of glucose during the nocturnal period (0000-0559), and average nocturnal sensor glucose (0000-0559) were significantly better with SG than DG. In contrast, SG had no effect on the time below range and minimum sensor glucose compared to DG.</p><p><strong>Conclusions: </strong>Switching from 0.75 mg DG to 0.5 mg SG in patients with T2DM improved glycemic variability, mean glycemic index, and daily variability without increasing the hypoglycemic index. The results suggest that switching to SG may be a useful option in patients experiencing inadequate glycemic control with DG.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13340-023-00640-2.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41105361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anemia combined with albuminuria increases the risk of cardiovascular and renal events, regardless of a reduced glomerular filtration rate, in patients with type 2 diabetes: a prospective observational study. 2型糖尿病患者无论肾小球滤过率降低,贫血合并蛋白尿都会增加心血管和肾脏事件的风险:一项前瞻性观察性研究。
IF 2.2 Q3 Medicine Pub Date : 2023-05-30 eCollection Date: 2023-10-01 DOI: 10.1007/s13340-023-00637-x
Hiroyuki Ito, Suzuko Matsumoto, Hideyuki Inoue, Takuma Izutsu, Eiji Kusano, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori, Michiko Togane

Aim: The incidence of cardiovascular and renal events was investigated in patients with type 2 diabetes who were classified according to anemia and the components of dialysis-independent chronic kidney disease (CKD) in a prospective observational study.

Methods: A population of 778 Japanese patients with type 2 diabetes was prospectively analyzed for 4 years. The outcomes were the incidence of cardiovascular events and renal events.

Results: In all subjects, the incidence of cardiovascular and renal events was found to be 5% and 11%, respectively. Even after adjusting for a reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2), the incidence of cardiovascular events was significantly higher (hazard ratio [HR]: 5.73) in patients with anemia and albuminuria than in those without anemia and albuminuria. The incidence of renal events was significantly higher in patients with no anemia and albuminuria (HR: 2.93) and further in those with anemia and albuminuria (HR: 7.56) than in those without anemia and albuminuria even after adjusting for a reduced eGFR.

Conclusion: Anemia combined with albuminuria is a risk factor for vascular events in patients with type 2 diabetes, regardless of the eGFR.

Supplementary information: The online version contains supplementary material available at 10.1007/s13340-023-00637-x.

目的:在一项前瞻性观察性研究中,对2型糖尿病患者的心血管和肾脏事件的发生率进行调查,这些患者根据贫血和透析非依赖性慢性肾脏疾病(CKD)的组成进行分类。方法:对778名日本2型糖尿病患者进行为期4年的前瞻性分析。结果是心血管事件和肾脏事件的发生率。结果:在所有受试者中,心血管和肾脏事件的发生率分别为5%和11%。即使在调整了估计肾小球滤过率(eGFR2)的降低后,贫血和蛋白尿患者的心血管事件发生率也显著高于无贫血和白蛋白尿患者(危险比[HR]:5.73)。即使在调整了eGFR降低后,没有贫血和蛋白尿的患者的肾事件发生率(HR:2.93)显著高于没有贫血和白蛋白尿的患者(HR:7.56)。结论:贫血合并蛋白尿是2型糖尿病患者血管事件的危险因素,无论eGFR如何。补充信息:在线版本包含可在10.1007/s13340-023-00637-x上获得的补充材料。
{"title":"Anemia combined with albuminuria increases the risk of cardiovascular and renal events, regardless of a reduced glomerular filtration rate, in patients with type 2 diabetes: a prospective observational study.","authors":"Hiroyuki Ito, Suzuko Matsumoto, Hideyuki Inoue, Takuma Izutsu, Eiji Kusano, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori, Michiko Togane","doi":"10.1007/s13340-023-00637-x","DOIUrl":"10.1007/s13340-023-00637-x","url":null,"abstract":"<p><strong>Aim: </strong>The incidence of cardiovascular and renal events was investigated in patients with type 2 diabetes who were classified according to anemia and the components of dialysis-independent chronic kidney disease (CKD) in a prospective observational study.</p><p><strong>Methods: </strong>A population of 778 Japanese patients with type 2 diabetes was prospectively analyzed for 4 years. The outcomes were the incidence of cardiovascular events and renal events.</p><p><strong>Results: </strong>In all subjects, the incidence of cardiovascular and renal events was found to be 5% and 11%, respectively. Even after adjusting for a reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m<sup>2</sup>), the incidence of cardiovascular events was significantly higher (hazard ratio [HR]: 5.73) in patients with anemia and albuminuria than in those without anemia and albuminuria. The incidence of renal events was significantly higher in patients with no anemia and albuminuria (HR: 2.93) and further in those with anemia and albuminuria (HR: 7.56) than in those without anemia and albuminuria even after adjusting for a reduced eGFR.</p><p><strong>Conclusion: </strong>Anemia combined with albuminuria is a risk factor for vascular events in patients with type 2 diabetes, regardless of the eGFR.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13340-023-00637-x.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41110692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Role of insulin action in the pathogenesis of diabetic complications. 更正:胰岛素作用在糖尿病并发症发病机制中的作用。
IF 2.2 Q3 Medicine Pub Date : 2023-05-27 eCollection Date: 2023-07-01 DOI: 10.1007/s13340-023-00636-y
Kyoichiro Tsuchiya

[This corrects the article DOI: 10.1007/s13340-022-00601-1.].

[这更正了文章DOI:10.1007/s13340-022-006011]。
{"title":"Correction to: Role of insulin action in the pathogenesis of diabetic complications.","authors":"Kyoichiro Tsuchiya","doi":"10.1007/s13340-023-00636-y","DOIUrl":"10.1007/s13340-023-00636-y","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1007/s13340-022-00601-1.].</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307759/pdf/13340_2023_Article_636.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10123142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determinants of phase angle in Japanese patients with diabetes. 日本糖尿病患者相位角的决定因素。
IF 2.2 Q3 Medicine Pub Date : 2023-05-25 eCollection Date: 2023-10-01 DOI: 10.1007/s13340-023-00633-1
Naokazu Muramae, Tomokazu Matsuda, Satoshi Inagaki, Hiroaki Takahashi, Kozue Abe, Saki Nakatani, Michiko Takahashi, Kenji Kato, Kazuhiko Sakaguchi, Wataru Ogawa

Phase angle, obtained using bioelectrical impedance analysis, non-invasively reflects the whole-body cellular condition and nutritional status and may be helpful as a prognostic factor. Patients with diabetes had a smaller phase angle than healthy subjects. However, the clinical significance of phase angle has not yet been elucidated. Therefore, the purpose of this study was to clarify the relationship between phase angle and HbA1c in patients with diabetes and the clinical relevance of phase angle. A retrospective, multicenter, cross-sectional study was conducted with Japanese patients with diabetes. Body composition was determined with bioelectrical impedance analysis, and this was used to obtain phase angle. Phase angle was assessed in relation to clinical parameters, body composition parameters, and HbA1c levels. A total of 655 patients were enrolled (400 men and 255 women, aged 57.1 ± 14.8 years, body mass index 25.6 ± 5.2 kg/m2, HbA1c 8.1 ± 1.9%). Even in patients with diabetes, the phase angle was higher in men than in women and did not differ between the types of diabetes. Multiple regression analysis, performed with phase angle as the objective variable, and age, sex, diabetes type, HbA1c, albumin level, and body mass index as explanatory variables, revealed that phase angle was negatively affected by HbA1c (B = - 0.043, 95% Confidence interval: - 0.07 to - 0.02, p < 0.001). HbA1c, age, sex, albumin level, and body mass index were independent determinants of phase angle in participants with diabetes.

使用生物电阻抗分析获得的相位角无创地反映了全身细胞状况和营养状况,可能有助于作为预后因素。糖尿病患者的相位角小于健康受试者。然而,相位角的临床意义尚未阐明。因此,本研究的目的是阐明糖尿病患者的相位角与HbA1c之间的关系以及相位角的临床相关性。对日本糖尿病患者进行了一项回顾性、多中心、横断面研究。通过生物电阻抗分析来确定身体成分,并将其用于获得相位角。根据临床参数、身体成分参数和HbA1c水平评估相位角。共有655名患者入选(400名男性和255名女性,年龄57.1岁 ± 14.8岁,体重指数25.6 ± 5.2 kg/m2,HbA1c 8.1 ± 1.9%)。即使在糖尿病患者中,男性的相位角也高于女性,并且不同类型的糖尿病之间没有差异。以相位角为客观变量,年龄、性别、糖尿病类型、HbA1c、白蛋白水平和体重指数为解释变量进行多元回归分析,结果表明相位角受HbA1c(B = -0.043,95%置信区间:-0.07至-0.02,p
{"title":"Determinants of phase angle in Japanese patients with diabetes.","authors":"Naokazu Muramae, Tomokazu Matsuda, Satoshi Inagaki, Hiroaki Takahashi, Kozue Abe, Saki Nakatani, Michiko Takahashi, Kenji Kato, Kazuhiko Sakaguchi, Wataru Ogawa","doi":"10.1007/s13340-023-00633-1","DOIUrl":"10.1007/s13340-023-00633-1","url":null,"abstract":"<p><p>Phase angle, obtained using bioelectrical impedance analysis, non-invasively reflects the whole-body cellular condition and nutritional status and may be helpful as a prognostic factor. Patients with diabetes had a smaller phase angle than healthy subjects. However, the clinical significance of phase angle has not yet been elucidated. Therefore, the purpose of this study was to clarify the relationship between phase angle and HbA1c in patients with diabetes and the clinical relevance of phase angle. A retrospective, multicenter, cross-sectional study was conducted with Japanese patients with diabetes. Body composition was determined with bioelectrical impedance analysis, and this was used to obtain phase angle. Phase angle was assessed in relation to clinical parameters, body composition parameters, and HbA1c levels. A total of 655 patients were enrolled (400 men and 255 women, aged 57.1 ± 14.8 years, body mass index 25.6 ± 5.2 kg/m<sup>2</sup>, HbA1c 8.1 ± 1.9%). Even in patients with diabetes, the phase angle was higher in men than in women and did not differ between the types of diabetes. Multiple regression analysis, performed with phase angle as the objective variable, and age, sex, diabetes type, HbA1c, albumin level, and body mass index as explanatory variables, revealed that phase angle was negatively affected by HbA1c (B = - 0.043, 95% Confidence interval: - 0.07 to - 0.02, p < 0.001). HbA1c, age, sex, albumin level, and body mass index were independent determinants of phase angle in participants with diabetes.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41113891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concurrent bacterial liver abscess and mild encephalitis/encephalopathy with reversible splenial lesion in a patient with poorly controlled type 2 diabetes. 2型糖尿病患者并发细菌性肝脓肿和轻度脑炎/脑病,伴有可逆性脾脏病变。
IF 2.2 Q3 Medicine Pub Date : 2023-05-15 eCollection Date: 2023-07-01 DOI: 10.1007/s13340-023-00635-z
Naohiro Sekikawa, Hiroyuki Hirai, Kazuhiro Sugimoto, Yoshiro Kusano

A 34-year-old man with poorly controlled type 2 diabetes was admitted to our hospital because of fever, headache, vomiting, and impaired consciousness. His hemoglobin A1c level was as high as 11.0%. Abdominal computed tomography revealed a bacterial liver abscess, while head magnetic resonance imaging simultaneously showed a high-signal lesion on diffusion-weighted imaging and a low-signal lesion on the apparent diffusion coefficient map of the splenium of the corpus callosum. No significant findings were detected in the cerebrospinal fluid. The latter findings led to a diagnosis of mild encephalitis/encephalopathy with reversible splenial lesions. His impaired consciousness resolved on Day 5 after treatment with ceftriaxone and metronidazole infusion and intensive insulin therapy; magnetic resonance imaging on Day 20 showed that the lesion in the splenium of the corpus callosum had disappeared. We propose that when a person with poorly controlled diabetes develops a bacterial infection and presents with impaired consciousness and headache, clinicians should consider the complications of mild encephalitis/encephalopathy with reversible splenial lesion.

一名34岁的2型糖尿病患者因发烧、头痛、呕吐和意识受损入院。他的血红蛋白A1c水平高达11.0%。腹部计算机断层扫描显示细菌性肝脓肿,而头部磁共振成像同时显示胼胝体压部扩散加权成像上的高信号病变和表观扩散系数图上的低信号病变。在脑脊液中未发现明显的发现。后一个发现导致诊断为轻度脑炎/脑病伴可逆性脾脏病变。在接受头孢曲松和甲硝唑输注以及强化胰岛素治疗后,他的意识受损在第5天得到缓解;第20天的磁共振成像显示胼胝体压部的病变已经消失。我们建议,当糖尿病控制不佳的人出现细菌感染并出现意识受损和头痛时,临床医生应考虑伴有可逆性脾损伤的轻度脑炎/脑病的并发症。
{"title":"Concurrent bacterial liver abscess and mild encephalitis/encephalopathy with reversible splenial lesion in a patient with poorly controlled type 2 diabetes.","authors":"Naohiro Sekikawa, Hiroyuki Hirai, Kazuhiro Sugimoto, Yoshiro Kusano","doi":"10.1007/s13340-023-00635-z","DOIUrl":"10.1007/s13340-023-00635-z","url":null,"abstract":"<p><p>A 34-year-old man with poorly controlled type 2 diabetes was admitted to our hospital because of fever, headache, vomiting, and impaired consciousness. His hemoglobin A1c level was as high as 11.0%. Abdominal computed tomography revealed a bacterial liver abscess, while head magnetic resonance imaging simultaneously showed a high-signal lesion on diffusion-weighted imaging and a low-signal lesion on the apparent diffusion coefficient map of the splenium of the corpus callosum. No significant findings were detected in the cerebrospinal fluid. The latter findings led to a diagnosis of mild encephalitis/encephalopathy with reversible splenial lesions. His impaired consciousness resolved on Day 5 after treatment with ceftriaxone and metronidazole infusion and intensive insulin therapy; magnetic resonance imaging on Day 20 showed that the lesion in the splenium of the corpus callosum had disappeared. We propose that when a person with poorly controlled diabetes develops a bacterial infection and presents with impaired consciousness and headache, clinicians should consider the complications of mild encephalitis/encephalopathy with reversible splenial lesion.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10105543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertriglyceridemia contributes significantly to high prevalence of small dense LDL-cholesterol in patients with type 2 diabetes, even when LDL-C targets are achieved. 在2型糖尿病患者中,即使达到LDL-C目标,高甘油三酯血症也会显著导致低密度脂蛋白胆固醇的高患病率。
IF 2.2 Q3 Medicine Pub Date : 2023-05-15 eCollection Date: 2023-07-01 DOI: 10.1007/s13340-023-00634-0
Tsutomu Hirano

Background: Small-dense (sd)LDL-cholesterol (C) is a potent risk factor for atherosclerotic cardiovascular disease (ASCVD) beyond LDL-C, and 35 mg/dL has been proposed as a cut-off value for high-sdLDL-C. sdLDL-C levels are strongly regulated by triglycerides (TG) and LDL-C levels. LDL-C has detailed targets for the prevention of ASCVD, while TG is only defined as abnormal at  ≥ 150 mg/dL. We investigated the effect of hypertriglyceridemia on the prevalence of high-sdLDL-C in patients with type 2 diabetes and explored the optimal TG levels that would suppress high-sdLDL-C.

Methods: Fasting plasma was obtained from 1569 patients with type 2 diabetes who were enrolled in the regional cohort study. sdLDL-C concentrations were measured by the homogeneous assay established by us. High-sdLDL-C was defined as ≤ 35 mg/dL according to the Hisayama Study. Hypertriglyceridemia was defined as ≥ 150 mg/dL.

Results: All lipid parameters except HDL-C were higher in the high-sdLDL-C group than in the normal-sdLDL-C group. The receiver operating characteristic (ROC) curves revealed that high sdLDL-C was identified sensitively by TG and LDL-C, with cut-off values of 115 mg/dL for TG and 110 mg/dL for LDL-C. The presence of hypertriglyceridemia increased the prevalence of high-sdLDL-C sixfold more than the normotriglyceridemic counterpart, regardless of statin use. This substantial influence of hypertriglyceridemia was found even within the control target of LDL-C levels (70-120 mg/dL) for diabetic subjects.

Conclusions: The TG cut-off for high-sdLDL-C was well below 150 mg/dL in a diabetic population. Amelioration of hypertriglyceridemia is needed even when LDL-C targets for diabetes are achieved.

背景:除LDL-C外,小密度(sd)低密度脂蛋白胆固醇(C)是动脉粥样硬化性心血管疾病(ASCVD)的一个有效风险因素,35 mg/dL已被提议作为高密度脂蛋白-胆固醇的临界值。sdLDL-C的水平受到甘油三酯(TG)和LDL-C水平的强烈调节。LDL-C有预防ASCVD的详细靶点,而TG仅被定义为 ≥ 150 mg/dL。我们研究了高甘油三酯血症对2型糖尿病患者高dLDL-C患病率的影响,并探讨了抑制高dLDL-C的最佳TG水平。sdLDL-C浓度通过我们建立的均匀测定法测定。High-sdLDL-C定义为 ≤ 根据Hisayama研究,35 mg/dL。高甘油三酯血症定义为 ≥ 150 mg/dL。结果:除HDL-C外,高dLDL-C组的所有脂质参数均高于正常dLDL-C组。受试者工作特性(ROC)曲线显示,高sdLDL-C通过TG和LDL-C敏感地识别,TG的截止值为115 mg/dL,LDL-C的截止值是110 mg/dL。无论他汀类药物的使用情况如何,高甘油三酯血症的存在使高dLDL-C的患病率增加了甘油三酯正常的六倍。高甘油三酯血症的这种实质性影响甚至在糖尿病受试者的LDL-C水平(70-120mg/dL)的控制目标范围内也被发现。结论:在糖尿病人群中,高dLDL-C的TG临界值远低于150 mg/dL。即使达到了糖尿病的LDL-C靶点,也需要改善高甘油三酯血症。
{"title":"Hypertriglyceridemia contributes significantly to high prevalence of small dense LDL-cholesterol in patients with type 2 diabetes, even when LDL-C targets are achieved.","authors":"Tsutomu Hirano","doi":"10.1007/s13340-023-00634-0","DOIUrl":"10.1007/s13340-023-00634-0","url":null,"abstract":"<p><strong>Background: </strong>Small-dense (sd)LDL-cholesterol (C) is a potent risk factor for atherosclerotic cardiovascular disease (ASCVD) beyond LDL-C, and 35 mg/dL has been proposed as a cut-off value for high-sdLDL-C. sdLDL-C levels are strongly regulated by triglycerides (TG) and LDL-C levels. LDL-C has detailed targets for the prevention of ASCVD, while TG is only defined as abnormal at  ≥ 150 mg/dL. We investigated the effect of hypertriglyceridemia on the prevalence of high-sdLDL-C in patients with type 2 diabetes and explored the optimal TG levels that would suppress high-sdLDL-C.</p><p><strong>Methods: </strong>Fasting plasma was obtained from 1569 patients with type 2 diabetes who were enrolled in the regional cohort study. sdLDL-C concentrations were measured by the homogeneous assay established by us. High-sdLDL-C was defined as ≤ 35 mg/dL according to the Hisayama Study. Hypertriglyceridemia was defined as ≥ 150 mg/dL.</p><p><strong>Results: </strong>All lipid parameters except HDL-C were higher in the high-sdLDL-C group than in the normal-sdLDL-C group. The receiver operating characteristic (ROC) curves revealed that high sdLDL-C was identified sensitively by TG and LDL-C, with cut-off values of 115 mg/dL for TG and 110 mg/dL for LDL-C. The presence of hypertriglyceridemia increased the prevalence of high-sdLDL-C sixfold more than the normotriglyceridemic counterpart, regardless of statin use. This substantial influence of hypertriglyceridemia was found even within the control target of LDL-C levels (70-120 mg/dL) for diabetic subjects.</p><p><strong>Conclusions: </strong>The TG cut-off for high-sdLDL-C was well below 150 mg/dL in a diabetic population. Amelioration of hypertriglyceridemia is needed even when LDL-C targets for diabetes are achieved.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9802057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetic lipemia as a predisposing state to acute pancreatitis: a case report and literature review. 糖尿病脂血症作为急性胰腺炎的易感状态:一例病例报告和文献综述。
IF 2.2 Q3 Medicine Pub Date : 2023-04-29 eCollection Date: 2023-07-01 DOI: 10.1007/s13340-023-00630-4
Yuka Hirakuni, Tomoyo Itonaga, Fumika Matsuda, Miwako Maeda, Kenji Ihara

Hypertriglyceridemia has been recognized as a common complication of diabetes ketoacidosis (DKA), whereas severe hypertriglyceridemia, also known as diabetic lipemia, rarely occurs and is associated with an increasing risk of acute pancreatitis. We report the case of a 4-year-old girl with new-onset DKA associated with remarkable hypertriglyceridemia. Her serum triglyceride (TG) level was as high as 2490 mg/dL on admission and 11,072 mg/dL on day two during treatment with hydration and intravenous insulin infusion, whereas the critical situation was successfully stabilized by standard treatment for DKA without the occurrence of pancreatitis. We reviewed 27 cases of diabetic lipemia with or without pancreatitis that were described in the relevant literature to identify risk factors for the occurrence of pancreatitis in children with DKA. As a result, the severity of hypertriglyceridemia or ketoacidosis, age at onset, type of diabetes, and presence of systemic hypotension, were not associated with the development of pancreatitis; however, the occurrence of pancreatitis in girls over 10 years old tended to be higher than that in boys. The serum TG levels and DKA successfully normalized in most of the cases with insulin infusion therapy with hydration, without other specific treatments (e.g., heparin therapy and plasmapheresis). We conclude that the occurrence of acute pancreatitis in diabetic lipemia could be avoided with appropriate hydration and insulin therapy, without specific treatment for hypertriglyceridemia.

高甘油三酯血症已被认为是糖尿病酮症酸中毒(DKA)的常见并发症,而严重的高甘油三酯血症,也称为糖尿病脂血症,很少发生,并与急性胰腺炎的风险增加有关。我们报告了一例4岁女孩新发DKA并伴有显著的高甘油三酯血症。她的血清甘油三酯(TG)水平在入院时高达2490 mg/dL,在水合和静脉注射胰岛素治疗的第二天高达11072 mg/dL。而DKA的标准治疗成功稳定了危急情况,没有发生胰腺炎。我们回顾了相关文献中描述的27例糖尿病性脂血症伴或不伴胰腺炎的病例,以确定DKA儿童发生胰腺炎的危险因素。因此,高甘油三酯血症或酮症酸中毒的严重程度、发病年龄、糖尿病类型和全身性低血压的存在与胰腺炎的发展无关;然而,10岁以上女孩胰腺炎的发生率往往高于男孩。在大多数情况下,在没有其他特定治疗(如肝素治疗和血浆置换)的情况下,通过水合胰岛素输注治疗,血清TG水平和DKA成功正常化。我们的结论是,糖尿病性脂血症中急性胰腺炎的发生可以通过适当的水合作用和胰岛素治疗来避免,而无需对高甘油三酯血症进行专门治疗。
{"title":"Diabetic lipemia as a predisposing state to acute pancreatitis: a case report and literature review.","authors":"Yuka Hirakuni, Tomoyo Itonaga, Fumika Matsuda, Miwako Maeda, Kenji Ihara","doi":"10.1007/s13340-023-00630-4","DOIUrl":"10.1007/s13340-023-00630-4","url":null,"abstract":"<p><p>Hypertriglyceridemia has been recognized as a common complication of diabetes ketoacidosis (DKA), whereas severe hypertriglyceridemia, also known as diabetic lipemia, rarely occurs and is associated with an increasing risk of acute pancreatitis. We report the case of a 4-year-old girl with new-onset DKA associated with remarkable hypertriglyceridemia. Her serum triglyceride (TG) level was as high as 2490 mg/dL on admission and 11,072 mg/dL on day two during treatment with hydration and intravenous insulin infusion, whereas the critical situation was successfully stabilized by standard treatment for DKA without the occurrence of pancreatitis. We reviewed 27 cases of diabetic lipemia with or without pancreatitis that were described in the relevant literature to identify risk factors for the occurrence of pancreatitis in children with DKA. As a result, the severity of hypertriglyceridemia or ketoacidosis, age at onset, type of diabetes, and presence of systemic hypotension, were not associated with the development of pancreatitis; however, the occurrence of pancreatitis in girls over 10 years old tended to be higher than that in boys. The serum TG levels and DKA successfully normalized in most of the cases with insulin infusion therapy with hydration, without other specific treatments (e.g., heparin therapy and plasmapheresis). We conclude that the occurrence of acute pancreatitis in diabetic lipemia could be avoided with appropriate hydration and insulin therapy, without specific treatment for hypertriglyceridemia.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307933/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10123141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Time course change of the insulin requirements during the perioperative period in hepatectomy and pancreatectomy by using an artificial pancreas STG-55. 更正:使用STG-55人工胰腺进行肝切除术和胰腺切除术围手术期胰岛素需求的时程变化。
IF 2.2 Q3 Medicine Pub Date : 2023-04-28 eCollection Date: 2023-07-01 DOI: 10.1007/s13340-023-00632-2
Sanae Teshigawara, Atsuhito Tone, Akihiro Katayama, Yusuke Imai, Toshihisa Tahara, Mayumi Senoo, Satoko Watanabe, Mitsuhiro Kaneto, Yasuyuki Shimomura, Chiaki Yagi, Hiroki Kajioka, Toru Kojima, Takefumi Niguma, Tatsuaki Nakatou

[This corrects the article DOI: 10.1007/s13340-023-00623-3.].

[这更正了文章DOI:10.1007/s1330-023-00623-3.]。
{"title":"Correction: Time course change of the insulin requirements during the perioperative period in hepatectomy and pancreatectomy by using an artificial pancreas STG-55.","authors":"Sanae Teshigawara,&nbsp;Atsuhito Tone,&nbsp;Akihiro Katayama,&nbsp;Yusuke Imai,&nbsp;Toshihisa Tahara,&nbsp;Mayumi Senoo,&nbsp;Satoko Watanabe,&nbsp;Mitsuhiro Kaneto,&nbsp;Yasuyuki Shimomura,&nbsp;Chiaki Yagi,&nbsp;Hiroki Kajioka,&nbsp;Toru Kojima,&nbsp;Takefumi Niguma,&nbsp;Tatsuaki Nakatou","doi":"10.1007/s13340-023-00632-2","DOIUrl":"10.1007/s13340-023-00632-2","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1007/s13340-023-00623-3.].</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307737/pdf/13340_2023_Article_632.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10123146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diabetology International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1